• Japanese
  • Korean
  • Chinese
Cover Image

Ocular Hypertension Global Clinical Trials Review, H1, 2014

GlobalData's clinical trial report, "Ocular Hypertension Global Clinical Trials Review, H1, 2014" provides data on the Ocular Hypertension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ocular Hypertension. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ocular Hypertension. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Ocular Hypertension
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Ocular Hypertension to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Ocular Hypertension
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Ocular Hypertension Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Ocular Hypertension
    • Sep 27, 2012: Amakem Initiates Phase IIa Proof Of Concept Study With AMA0076 In Patients With Glaucoma And Ocular Hypertension
    • Aug 20, 2012: Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study For Treatment Of Glaucoma
    • Jun 13, 2012: Zeltia Subsidiary Sylentis Commences Phase II Clinical Trial With SYL040012 For Treatment Of Ocular Hypertension Associated With Glaucoma
    • Mar 13, 2012: NicOx, Bausch + Lomb's Glaucoma Candidate BOL-303259-X Meets Primary Endpoint In Phase IIb Study
    • Feb 09, 2012: Altheos Initiates Phase IIa Clinical Trial For Its Lead Glaucoma Drug Candidate, ATS907
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Kowa Company, Ltd.
      • Clinical Trial Overview of Kowa Company, Ltd.
      • QLT Inc.
      • Clinical Trial Overview of QLT Inc.
      • Aerie Pharmaceuticals, Inc.
      • Clinical Trial Overview of Aerie Pharmaceuticals, Inc.
      • Mati Therapeutics Inc.
      • Clinical Trial Overview of Mati Therapeutics Inc.
      • Bausch & Lomb Incorporated
      • Clinical Trial Overview of Bausch & Lomb Incorporated
    • Clinical Trial Overview of Top Institutes / Government
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Aristotle University Of Thessaloniki
      • Clinical Trial Overview of Aristotle University Of Thessaloniki
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • The University of Tokyo
      • Clinical Trial Overview of The University of Tokyo
      • Meir Medical Center
      • Clinical Trial Overview of Meir Medical Center
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Johns Hopkins University
      • Clinical Trial Overview of Johns Hopkins University
      • Walter Reed Army Medical Center
      • Clinical Trial Overview of Walter Reed Army Medical Center
      • Universita di Bologna
      • Clinical Trial Overview of Universita di Bologna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Region, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ocular Hypertension Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Ocular Hypertension Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Ocular Hypertension Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Bausch & Lomb Incorporated, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Meir Medical Center, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Walter Reed Army Medical Center, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita di Bologna, 2014*

List of Figures

  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, G7 Countries (%), 2014*
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Hypertension Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Ocular Hypertension to Ophthalmology Clinical Trials, E7 Countries (%), 2014*
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Ocular Hypertension Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Ocular Hypertension Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Ocular Hypertension Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Ocular Hypertension Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published